Medtronic Kappa/Sigma pacer recall is Class I
This article was originally published in The Gray Sheet
Executive Summary
Firm's May 18 "Dear Doctor" letter advising of potential wire separations in certain Kappa and Sigma pacemakers is deemed a Class I recall by FDA, the most serious category, the agency announces June 11. Medtronic had warned that wire separations in certain models could cause a loss of rate response, premature battery depletion, loss of telemetry or no output. Therefore, the firm advised that physicians consider device replacement for patients who are pacemaker-dependent. Medtronic has made no new recommendations as a result of the recall classification (1"The Gray Sheet" May 25, 2009, p. 15)
You may also be interested in...
Medtronic “Dear Doctor” Letter Impacts 37,000 Kappa/Sigma Pacemakers
Medtronic is advising physicians to consider replacing certain Kappa and Sigma pacemakers after the devices were shown to fail at a higher-than-expected rate
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.